Biotechnology Stocks
| # | Son 7 Gün | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1497 | ADPT Adaptive Biotechnologies Corporation - Common Stock | 25.35 USD | -2.46% | +1.52% | +11.58% | +46.87% | 4.05 B USD | ||
| 1517 | LEGN Legend Biotech Corporation - American Depositary Shares | 21.01 USD | -3.71% | +3.29% | +2.24% | -34.30% | 3.89 B USD | ||
| 1519 | TNGX Tango Therapeutics, Inc. - Common Stock | 23.16 USD | -3.02% | -9.57% | -13.52% | +238.10% | 3.91 B USD | ||
| 1522 | DNLI Denali Therapeutics Inc. - Common Stock | 23.75 USD | -4.70% | -2.22% | +0.68% | +46.88% | 3.80 B USD | ||
| 1531 | VKTX Viking Therapeutics, Inc. - Common Stock | 32.94 USD | -2.80% | -0.18% | -6.98% | +27.62% | 3.84 B USD | ||
| 1549 | RCUS Arcus Biosciences, Inc. Common Stock | 29.71 USD | -2.11% | +0.20% | +3.23% | +181.08% | 3.78 B USD | ||
| 1554 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.62 USD | +2.56% | -0.77% | +14.60% | +84.15% | 3.94 B USD | ||
| 1556 | IDYA IDEAYA Biosciences, Inc. - Common Stock | 39.29 USD | -0.96% | +8.12% | +8.06% | +20.60% | 3.79 B USD | ||
| 1565 | IOVA Iovance Biotherapeutics, Inc. - Common Stock | 7.89 USD | -4.83% | +15.86% | +57.17% | +207.00% | 3.57 B USD | ||
| 1614 | GPCR Structure Therapeutics Inc - American Depositary Shares | 47.99 USD | -2.24% | -11.88% | -2.76% | +79.47% | 3.42 B USD | ||
| 1618 | ABCL AbCellera Biologics Inc. - Common Shares | 10.76 USD | -4.95% | -2.00% | +100.00% | +147.36% | 3.30 B USD | ||
| 1635 | VCYT Veracyte, Inc. - Common Stock | 41.25 USD | -2.51% | -1.01% | -28.61% | +11.79% | 3.32 B USD | ||
| 1650 | QURE uniQure N.V. - Ordinary Shares | 46.80 USD | -3.25% | -1.74% | +21.56% | +199.23% | 3.25 B USD | ||
| 1655 | NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 26.90 USD | -3.48% | +0.79% | -10.66% | -25.83% | 3.22 B USD | ||
| 1673 | IMNM Immunome, Inc. - Common Stock | 27.89 USD | -2.21% | +3.33% | +23.46% | +168.69% | 3.17 B USD | ||
| 1688 | TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 71.77 USD | -1.28% | +3.56% | +22.18% | +8.64% | 3.15 B USD | ||
| 1695 | CLDX Celldex Therapeutics, Inc. - Common Stock | 39.93 USD | -1.11% | -5.18% | +11.91% | +46.59% | 3.14 B USD | ||
| 1701 | ARQT Arcutis Biotherapeutics, Inc. - Common stock | 24.78 USD | -1.20% | -4.98% | -10.28% | +54.88% | 3.11 B USD | ||
| 1706 | ALMS Alumis Inc. - Common Stock | 22.95 USD | -5.05% | -8.35% | -17.42% | +408.87% | 2.97 B USD | ||
| 1707 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 14.28 USD | -7.63% | +14.15% | +26.82% | +647.64% | 2.88 B USD |
Haberler Biotechnology Stocks
Deutsche Bank, argenx hissesini değerleme nedeniyle Tut’a düşürdü
Monte Rosa Therapeutics hissesi neden düşüyor?
Biomea Fusion hisseleri diyabet çalışması kayıt tamamlanmasıyla yükseldi
Monte Rosa hisseleri faz 2 prostat kanseri çalışması başlarken düştü
H.C. Wainwright, Biomea Fusion hissesi için hedef fiyatı korudu
Crinetics Pharmaceuticals hissesi 84,8 dolarda zirve yaptı
FDA, Capricor’un deramiocel incelemesini 22 Kasım’a uzattı
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |